Status:
COMPLETED
The Canada Lymph Node Score Project: A Crossover Trial
Lead Sponsor:
St. Joseph's Healthcare Hamilton
Collaborating Sponsors:
Health Sciences Centre, Winnipeg, Manitoba
Royal Alexandra Hospital
Conditions:
Lung Cancer
Non Small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Before deciding on treatment for patients with lung cancer, a critical step in the investigation is finding out whether the lymph nodes in the chest contain cancer cells. This is accomplished with a b...
Detailed Description
Treatment decisions in Non-Small Lung Cancer (NSCLC) are reliant on a thorough staging process that includes imaging with Computed Tomography (CT), Positron Emission Tomography (PET) and Systematic Sa...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Both CT and PET scans completed prior to EBUS
- Suspected or confirmed NSCLC requiring mediastinal staging
- cN0-cN1 as indicated by CT and PET scans
Exclusion
- Patients with cN0 disease AND peripheral tumors AND tumor \< 2 cm in diameter, as they do not require mediastinal staging
- Evidence of cN2 disease or higher on CT and PET scans
Key Trial Info
Start Date :
November 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04342377
Start Date
November 30 2020
End Date
June 30 2022
Last Update
July 27 2022
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Alexandra Hospital
Edmonton, Alberta, Canada, T5H 3V9
2
Health Sciences Centre
Winnipeg, Manitoba, Canada, R3A 1R9
3
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada, L8N 4A6
4
McMaster University
Hamilton, Ontario, Canada, L8S 4L8